Pure MHC Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

Pure MHC General Information

Description

Developer of a biotechnology platform intended to create a novel class of therapeutics for the treatment of cancer and infectious disease. The company's platform specializes in disease-specific target identification, and validation as well as immunotherapeutic drug development for cancer, infectious, and autoimmune diseases and allergy, enabling healthcare practitioners to avail breakthrough therapeutic target discovery and validation with further drug development applications.

Contact Information

Website
www.puremhc.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 7500 Rialto Boulevard, Building 2
  • Suite 260
  • Austin, TX 78735
  • United States
+1 (512)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 7500 Rialto Boulevard, Building 2
  • Suite 260
  • Austin, TX 78735
  • United States
+1 (512)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pure MHC Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Apr-2021 Completed Generating Revenue
1. Later Stage VC 18-Jun-2008 Completed Generating Revenue
To view Pure MHC’s complete valuation and funding history, request access »

Pure MHC Patents

Pure MHC Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2009151487-A1 Methods of assaying vaccine potency Inactive 13-Jun-2008
EP-2262834-A2 Antibodies as t cell receptor mimics, methods of production and uses thereof Inactive 27-Feb-2008
EP-2262834-A4 Antibodies as t cell receptor mimics, methods of production and uses thereof Inactive 27-Feb-2008
WO-2009108372-A2 Antibodies as t cell receptor mimics, methods of production and uses thereof Inactive 27-Feb-2008
WO-2009108372-A3 Antibodies as t cell receptor mimics, methods of production and uses thereof Inactive 27-Feb-2008 C07K16/2833
To view Pure MHC’s complete patent history, request access »

Pure MHC Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pure MHC FAQs

  • When was Pure MHC founded?

    Pure MHC was founded in 2003.

  • Where is Pure MHC headquartered?

    Pure MHC is headquartered in Austin, TX.

  • What is the size of Pure MHC?

    Pure MHC has 6 total employees.

  • What industry is Pure MHC in?

    Pure MHC’s primary industry is Drug Discovery.

  • Is Pure MHC a private or public company?

    Pure MHC is a Private company.

  • What is Pure MHC’s current revenue?

    The current revenue for Pure MHC is .

  • How much funding has Pure MHC raised over time?

    Pure MHC has raised $2M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process